RECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II ANTIGENS BY TWO ANTI-HLA-DR MONOCLONAL ANTIBODIES ON CANINE MARROW CELLS CORRELATES WITH EFFECTS ON IN VITRO AND IN VIVO HEMATOPOIESIS1
Masaki Yamaguchi(RIKEN), H. Joachim Deeg(Fred Hutch Cancer Center), Louise E. Kimball(Fred Hutch Cancer Center), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), William W. Kwok(Virginia Mason Medical Center), Dae Sik Hong, Peter A. McSweeney(Mesoblast (United States)), C Beckham(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Geoffrey M. Gersuk(Children's Hospital of Los Angeles)
Cited by 5
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k